The pancreatitis therapeutics market has been estimated to grow at a compound annual growth rate (CAGR) of 3.6% to 2019, increasing from a market value of $36 million in 2011, to be worth $47.7 million by 2019.
With current treatment options within the pancreatitis market offering only symptomatic relief, and there also being no currently approved disease-modifying drugs in the market and only one in the pipeline (somatostatin), it is no surprise that the market is expected to show a slow growth through to 2019.
Pancreatitis is inflammation of the pancreas. It occurs when pancreatic enzymes that digest food are activated in the pancreas instead of the small intestine. It can occur in two forms, either acute, beginning suddenly and lasting a few days, or chronic, occurring over many years.
The current pancreatitis therapeutics market lacks disease-modifying drugs, resulting in significant unmet need in the treatment of pancreatitis. The only disease-modifying drug in the late stage of the pipeline in the pancreatitis therapeutics market is somatostatin, which is currently undergoing a university sponsored trial.
This unmet need is expected to persist within the market to 2019 as patients are forced to depend on symptomatic relief.
With the pancreatitis therapeutics market currently only having one approved drug there is huge potential for new entrants within the market that can halt or reverse disease progression as well as offering good efficacy and safety profiles.
For more information on the pancreatitis therapeutics market, see the latest research: Pancreatitis Therapeutics Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.